- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 271/08 - 1,2,5-OxadiazolesHydrogenated 1,2,5-oxadiazoles
Patent holdings for IPC class C07D 271/08
Total number of patents in this class: 204
10-year publication summary
|
16
|
19
|
37
|
23
|
6
|
17
|
2
|
6
|
5
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Incyte Holdings Corporation | 654 |
23 |
| Bayer Cropscience AG | 2135 |
20 |
| Incyte Corporation | 971 |
12 |
| BASF SE | 20501 |
10 |
| Bayer AG | 3221 |
8 |
| Incyte Holdings Corporation and Incyte Corporation | 89 |
7 |
| Bayer Intellectual Property GmbH | 2566 |
6 |
| Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences | 167 |
5 |
| Nicox S.A. | 148 |
4 |
| Nanjing Huawe Medicine Technology Group Co., Ltd. | 9 |
4 |
| Dice Alpha, Inc. | 15 |
4 |
| Merck Sharp & Dohme LLC | 3750 |
4 |
| Merck Sharp & Dohme Corp. | 2215 |
3 |
| Hinova Pharmaceuticals Inc. | 88 |
3 |
| Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 279 |
3 |
| Shandong Luye Pharmaceutical Co., Ltd. | 63 |
3 |
| Shanghai Hansoh Biomedical Co., Ltd. | 234 |
3 |
| Galderma Research & Development | 415 |
2 |
| Hangzhou Normal University | 56 |
2 |
| Hydra Biosciences, Inc. | 42 |
2 |
| Other owners | 76 |